Grizzly Bulls
Financial research concept

Contract Research Backlog

tracks contracted clinical-research work that has not yet converted to revenue, with timing and cancellation risk that make the balance different from guaranteed future sales.

By Lee BaileyPublished Sep 28, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 28, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
10 connected conceptsPart of the reviewed Contract Research Organization Economics; issuer definitions remain distinct where disclosed.
Company examples
3 reviewed companiesRelationships reflect supported examples, not a normalized cross-company KPI ranking.
  1. A backlog balance is not a revenue forecast by itself
  2. The policy can move the number without changing customer demand
  3. Part of the Contract Research Organization Economics
  4. See It in Company Research
  5. Continue Research

Contract research backlog is the value of clinical-research work expected from existing customer commitments that has not yet been recognized as revenue under the issuer's backlog policy.

The scale can be enormous relative to current revenue. At June 30, 2026, IQVIA reported $34.2B of R&DS contracted backlog, ICON reported $23.4B, and Medpace reported $3.014B. Those balances are not directly comparable without reading what each company includes.

A backlog balance is not a revenue forecast by itself

Clinical studies can run for years. Sponsors can delay enrollment, change scope, encounter regulatory setbacks, or cancel programs. Medpace explicitly says backlog can move because of awards, scope changes, cancellations, revenue recognition, and foreign exchange. IQVIA likewise warns that delayed projects can stay in backlog even when the expected revenue timing changes.

That is why the useful question is not simply whether backlog grew. Investors need the next-twelve-month backlog and, where disclosed, a backlog conversion rate to judge how quickly the contracted work is moving into reported revenue.

The policy can move the number without changing customer demand

ICON changed its cancellation policy effective October 1, 2025 and adjusted reported backlog downward by $3.9B to $21.1B at that date. The company said its treatment of awards entering backlog did not change.

That episode is a reminder to inspect the backlog inclusion policy before treating a historical series as mechanically comparable. A methodology reset can be economically important even when no new study was won or lost that day.

Primary sources: IQVIA second-quarter 2026 Form 10-Q, ICON second-quarter 2026 results, ICON fourth-quarter 2025 results, and Medpace 2025 Form 10-K.

Part of the Contract Research Organization Economics

Connect clinical-research awards, cancellations, book-to-bill, backlog policy and conversion, near-term revenue visibility, and reimbursed pass-through activity across contract research organizations.

Browse the full operating model in Company Analysis →
Where this concept fits
  • Backlog quality, timing, and conversionCurrent relationship
    Backlog captures expected contracted work, inclusion policy defines which work qualifies, RPO preserves a separate accounting boundary, next-twelve-month backlog shows near-term timing, and backlog conversion indicates how quickly the booked work becomes revenue.
    CRO BacklogCurrent conceptCRO Backlog ConversionCRO Backlog PolicyCRO Backlog vs. RPOCRO NTM Backlog
  • Awards, cancellations, and demand coverage
    Net new awards or bookings incorporate cancellations, while book-to-bill compares that net commercial inflow with current revenue. Together they show whether newly won work is replenishing the revenue base without treating gross wins as guaranteed future revenue.
    CRO Book-to-BillCRO CancellationsCRO Net New Awards
  • Pass-through costs and underlying service growth
    Reimbursed expenses can materially change reported clinical-research revenue and costs without adding equivalent service economics, so revenue excluding reimbursed expenses helps isolate the underlying service-growth read.
    CRO Reimbursed ExpensesCRO Revenue ex Reimbursements

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare CRO backlog quality

Compare contracted clinical-research work while preserving cancellation rights, study duration, scope changes, foreign exchange, and issuer-specific backlog policy.

Continue research

Explore more topics in the Financial Research Encyclopedia.